« Previous
Next »
The Journal of Arthroplasty
Volume 25, Issue 8
, Pages
1267-1274
, December 2010
Dabigatran Etexilate Prevents Venous Thromboembolism After Total Knee Arthroplasty in Japanese Patients With a Safety Profile Comparable to Placebo
To access this article, please choose from the options below
Benefits or funds were received in particular or total support of the research material described in this article. These benefits and/or support were received from the following sources: Boehringer Ingelheim Co, Ltd (Kawanishi, Japan).
Fuji is the coordinating investigator for Nippon Boehringer Ingelheim in this clinical study. Fujita is the chair of adjudication committee for diagnostic tests. Sato and Ujihira are consultants for Nippon Boehringer Ingelheim.
PII: S0883-5403(09)00410-0
doi: 10.1016/j.arth.2009.08.010
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Arthroplasty
Volume 25, Issue 8
, Pages
1267-1274
, December 2010
